Health
The Drug That Degrades Cancer's Most Wanted Mutation
Setidegrasib targets KRAS G12D — a notoriously elusive oncogene — and early results are rewriting what's possible in lung and pancreatic cancer.
Tag
Setidegrasib targets KRAS G12D — a notoriously elusive oncogene — and early results are rewriting what's possible in lung and pancreatic cancer.